Herrmann T R W, Gross A J, Schultheiss D, Kaufmann P M, Jonas U, Burchardt M
Department of Urology and Pediatric Urology, Medical School of Hannover (MHH), Carl Neuberg Street 1, 30625, Hannover, Germany.
World J Urol. 2006 Sep;24(4):389-96. doi: 10.1007/s00345-006-0098-7. Epub 2006 Jun 3.
Minimally invasive therapies for treatment of benign prostatic hyperplasia (BPH) compete with the gold standard transurethral resection of the prostate (TURP). Comparisons of efficacy and safety have broadened the knowledge of different treatment modalities. Concerns of quality of life such as unaltered sexual function as well as cost considerations drive the market to develop techniques of lower level invasiveness. Among the competitors the office based transurethral microwave thermotherapy (TUMT) provides the broadest scale of scientific data. Numerous manufacturers sell various modifications of this technology. According to different clinical studies TUMT proved to be an effective, safe, and durable therapy for the treatment of lower urinary tract symptoms (LUTS) secondary to BPH. However, TURP still holds the steadier long-term results and is more effective to reduce obstruction as well as other LUTS.
治疗良性前列腺增生（BPH）的微创疗法与前列腺电切术（TURP）这一金标准疗法相互竞争。疗效和安全性的比较拓宽了人们对不同治疗方式的认识。对性功能不受影响等生活质量问题的关注以及成本考量推动市场开发侵入性更低的技术。在众多竞争疗法中，门诊经尿道微波热疗（TUMT）拥有最广泛的科学数据。许多制造商销售该技术的各种改良版本。根据不同的临床研究，TUMT被证明是治疗BPH继发下尿路症状（LUTS）的一种有效、安全且持久的疗法。然而，TURP仍保持更稳定的长期效果，在减轻梗阻及其他LUTS方面更有效。
